slides · global inventory
Transformation Tale
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,484
Current window 1,171-1,200
Pages 83
Rows per page 30
Arc
1,171-1,200 of 2,484
67
Uses a causal chain/additive logic to explain growth components.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
68
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
69
LSD likely stands for Low Single Digit growth.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
70
The slide highlights the scale of operations (70+ conditions, >100 countries) and the technical workflow from sample collection to advanced testing.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
71
The slide uses a simple flow diagram to connect strategic initiatives to a financial outcome.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
72
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
73
The slide uses a choropleth map for the US and a list of country-specific metrics for international comparison.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
74
The chart shows the growth of conditions approved for newborn screening (NBS) from 54 in 2007 to 64 in 2024.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
75
The slide highlights two key innovation areas: Metachromatic Leukodystrophy (MLD) and Next Generation Sequencing (NGS) for newborn screening.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
76
The slide uses a mathematical equation format to explain growth components.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
77
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
78
Uses a simple additive equation visual to explain the weighted average growth rate.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Build Up1 hit
79
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
80
The slide uses a stacked bar chart to show the shift in medical focus and a process-like diagram to list the pillars of the new era.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
81
The slide uses a path-based journey framework to illustrate the end-to-end process from drug discovery to patient monitoring.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
82
The diagram uses a hub-and-spoke style with a central 'Customer Needs' node connected to six peripheral nodes, which are also interconnected.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
83
The slide uses a visual flow to represent M&A activity culminating in the Revvity brand.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
84
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
85
The slide uses a value chain / process flow diagram to illustrate how the company's business units align with the drug and diagnostic development lifecycle.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
86
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
87
The slide uses an infinity loop diagram to connect diagnostic testing and therapeutic approaches.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
88
The slide highlights a specific diagnostic application (T1D) and the cross-functional collaboration (Euroimmun, Reproductive Health, Global Lab Network) to deliver a DBS card assay.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
89
The slide uses a scientific diagram to illustrate the mechanism of the base editing technology.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
90
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Time Machine1 hit
91
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
92
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
93
The slide uses a color-coded approach (purple for 2019, yellow for 2024E) to highlight performance improvement.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
94
2024 Investor Day2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
95
The slide uses a three-column layout to group initiatives under functional areas.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Before After1 hit
96
LSD = Low Single Digit, MSD = Mid Single Digit. The slide shows a shift in revenue and margin profiles due to organizational restructuring.2024 Investor Day · Revvity
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit